Analyst Ratings for Biogen (biib)
biib Rating Summary
biib Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $157.00 (HSBC)
- Average: $229.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$229.43 (+5.8%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$229.43 (+5.8%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Wolfe Research | Alexandria Hammond | Upgrade | Outperform (Peerperform) |
300.00 (N/A) |
208.87 (216.78) |
3.79% | Details |
| 7/13/2026 | Truist Securities | Danielle Brill | Upgrade | Buy (Hold) |
235.00 (N/A) |
199.15 (216.78) |
8.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
